Baxter - 44 Year Stock Price History | BAX
Historical daily share price chart and data for Baxter since 1981 adjusted for splits and dividends. The latest closing stock price for Baxter as of August 11, 2025 is 23.46.
- The all-time high Baxter stock closing price was 84.49 on April 20, 2020.
- The Baxter 52-week high stock price is 40.49, which is 72.6% above the current share price.
- The Baxter 52-week low stock price is 21.33, which is 9.1% below the current share price.
- The average Baxter stock price for the last 52 weeks is 32.45.
| Baxter Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 30.5298 | 28.9570 | 36.3675 | 21.7600 | 23.4600 | -18.71% |
| 2024 | 36.0112 | 37.3689 | 42.3972 | 28.3336 | 28.8581 | -22.40% |
| 2023 | 38.7614 | 47.6825 | 49.1119 | 30.2581 | 37.1862 | -21.91% |
| 2022 | 62.3073 | 79.7576 | 82.1264 | 46.4400 | 47.6171 | -39.58% |
| 2021 | 73.5250 | 72.5438 | 80.0514 | 67.2341 | 78.8120 | 8.48% |
| 2020 | 75.7059 | 76.8765 | 84.4939 | 64.2365 | 72.6525 | -2.95% |
| 2019 | 70.9768 | 57.8443 | 80.1624 | 57.1179 | 74.8621 | 28.40% |
| 2018 | 61.5606 | 58.8864 | 68.7246 | 54.3790 | 58.3049 | 2.89% |
| 2017 | 50.6086 | 38.5594 | 57.7624 | 38.5594 | 56.6684 | 47.30% |
| 2016 | 37.8643 | 31.8801 | 42.5310 | 29.8130 | 38.4727 | 17.58% |
| 2015 | 31.9378 | 33.9449 | 35.9134 | 27.5935 | 32.7206 | -3.58% |
| 2014 | 33.4647 | 32.0371 | 35.6534 | 30.7869 | 33.9356 | 5.38% |
| 2013 | 32.1132 | 31.3240 | 34.4634 | 29.5831 | 32.2038 | 4.34% |
| 2012 | 26.8685 | 23.4016 | 31.8611 | 22.7024 | 30.8656 | 34.72% |
| 2011 | 25.1664 | 23.4061 | 28.8977 | 22.0634 | 22.9107 | -2.25% |
| 2010 | 23.1053 | 26.9899 | 28.5735 | 18.7388 | 23.4385 | -13.74% |
| 2009 | 25.0135 | 25.5036 | 28.0132 | 21.4891 | 27.1705 | 9.50% |
| 2008 | 28.4509 | 26.7583 | 32.9444 | 22.4569 | 24.8137 | -7.68% |
| 2007 | 25.3647 | 21.5307 | 28.2864 | 21.4521 | 26.8788 | 25.14% |
| 2006 | 18.9542 | 17.7617 | 21.8595 | 16.4143 | 21.4798 | 23.21% |
| 2005 | 17.2564 | 16.0300 | 18.9609 | 15.4512 | 17.4329 | 9.00% |
| 2004 | 14.5777 | 13.9695 | 16.0161 | 13.3166 | 15.9929 | 13.17% |
| 2003 | 12.3064 | 13.2842 | 14.4464 | 8.5938 | 14.1315 | 9.00% |
| 2002 | 19.9769 | 24.5866 | 27.5963 | 11.2145 | 12.9647 | -47.79% |
| 2001 | 22.4230 | 20.7493 | 25.6979 | 18.8683 | 24.8321 | 21.46% |
| 2000 | 16.5218 | 14.1559 | 20.5178 | 11.9503 | 20.4454 | 41.13% |
| 1999 | 15.0950 | 14.5739 | 17.5147 | 13.5360 | 14.4874 | -2.33% |
| 1998 | 13.2133 | 11.5611 | 15.2226 | 11.2295 | 14.8334 | 27.51% |
| 1997 | 11.5935 | 9.3699 | 13.8531 | 9.3699 | 11.6332 | 23.02% |
| 1996 | 10.1098 | 9.6006 | 11.0421 | 9.2258 | 9.4565 | -2.09% |
| 1995 | 8.2063 | 6.4868 | 9.8023 | 6.2562 | 9.6582 | 48.23% |
| 1994 | 5.8933 | 5.6219 | 6.6021 | 5.0741 | 6.5157 | 15.90% |
| 1993 | 6.2182 | 7.3517 | 7.3517 | 4.6705 | 5.6219 | -24.71% |
| 1992 | 7.5860 | 8.1828 | 8.3652 | 6.4413 | 7.4670 | -10.46% |
| 1991 | 7.0312 | 5.6736 | 8.4173 | 5.3110 | 8.3391 | 44.34% |
| 1990 | 5.0852 | 5.2485 | 6.0015 | 4.2526 | 5.7773 | 12.28% |
| 1989 | 4.4136 | 3.6160 | 5.2662 | 3.6160 | 5.1456 | 42.30% |
| 1988 | 4.2498 | 4.7957 | 5.3086 | 3.3852 | 3.6160 | -22.53% |
| 1987 | 4.9712 | 3.8981 | 5.9754 | 3.7699 | 4.6675 | 18.18% |
| 1986 | 3.7238 | 3.1800 | 4.3341 | 3.1288 | 3.9494 | 22.22% |
| 1985 | 2.9968 | 2.6928 | 3.4108 | 2.5645 | 3.2313 | 20.00% |
| 1984 | 3.3439 | 4.7700 | 5.0265 | 2.4620 | 2.6928 | -43.55% |
| 1983 | 5.4888 | 4.7572 | 6.4242 | 4.3854 | 4.7700 | -3.88% |
| 1982 | 3.9795 | 3.5134 | 5.1804 | 3.2057 | 4.9624 | 44.40% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $12.168B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.709B | 27.40 |
| Boston Scientific (BSX) | United States | $152.828B | 36.44 |
| Stryker (SYK) | United States | $144.352B | 29.38 |
| EssilorLuxottica (ESLOY) | France | $136.813B | 0.00 |
| Medtronic (MDT) | Ireland | $119.054B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.435B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.853B | 24.46 |
| ResMed (RMD) | United States | $41.628B | 29.73 |
| GE HealthCare Technologies (GEHC) | United States | $32.872B | 15.45 |
| Agilent Technologies (A) | United States | $32.560B | 21.23 |
| Terumo (TRUMY) | Japan | $27.538B | 32.63 |
| Koninklijke Philips (PHG) | Netherlands | $25.845B | 17.10 |
| Insulet (PODD) | United States | $21.612B | 72.43 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.663B | 12.52 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.829B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.599B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.150B | 26.26 |
| Lantheus Holdings (LNTH) | United States | $3.889B | 10.52 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.364B | 23.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.227B | 14.32 |
| Perrigo (PRGO) | Ireland | $3.102B | 7.75 |
| ICU Medical (ICUI) | United States | $2.786B | 18.97 |
| Haemonetics (HAE) | United States | $2.601B | 11.61 |
| LeMaitre Vascular (LMAT) | United States | $2.089B | 44.80 |
| AtriCure (ATRC) | United States | $1.755B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.624B | 10.22 |
| Green Thumb Industries (GTBIF) | United States | $1.509B | 64.82 |
| Curaleaf Holdings (CURLF) | Canada | $1.368B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.240B | 17.67 |
| Phibro Animal Health (PAHC) | United States | $1.139B | 14.56 |
| Acuren (TIC) | United States | $1.138B | 0.00 |
| Neogen (NEOG) | United States | $1.103B | 17.52 |
| BioLife Solutions (BLFS) | United States | $1.086B | 2268.00 |
| InMode (INMD) | Israel | $0.892B | 8.25 |
| Valneva SE (VALN) | France | $0.775B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.746B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.714B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.560B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| ZimVie (ZIMV) | United States | $0.530B | 20.45 |
| Surmodics (SRDX) | United States | $0.506B | 0.00 |
| CeriBell (CBLL) | United States | $0.473B | 0.00 |
| SNDL (SNDL) | Canada | $0.441B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.414B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.393B | 13.54 |
| Evolus (EOLS) | United States | $0.382B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.347B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.341B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 20.88 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.253B | 0.00 |
| Omeros (OMER) | United States | $0.251B | 0.00 |
| Cerus (CERS) | United States | $0.232B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.80 |
| Quanterix (QTRX) | United States | $0.221B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.220B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.214B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.203B | 0.00 |
| Exagen (XGN) | United States | $0.202B | 0.00 |
| Organigram Global (OGI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.06 |
| High Tide (HITI) | Canada | $0.176B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.170B | 0.00 |
| Biote (BTMD) | United States | $0.158B | 4.72 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| Safety Shot (SHOT) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.33 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Veru (VERU) | United States | $0.055B | 0.00 |
| Zynex (ZYXI) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 32.50 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.11 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.017B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |